Stephen J. Lane

ORCID: 0000-0003-2455-8263
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Estrogen and related hormone effects
  • Respiratory Support and Mechanisms
  • Allergic Rhinitis and Sensitization
  • Mobile Health and mHealth Applications
  • Eosinophilic Esophagitis
  • Pediatric health and respiratory diseases
  • Adrenal Hormones and Disorders
  • Family and Patient Care in Intensive Care Units
  • Esophageal and GI Pathology
  • Health, Environment, Cognitive Aging
  • Pleural and Pulmonary Diseases
  • Urticaria and Related Conditions
  • Immune Response and Inflammation
  • Immune Cell Function and Interaction
  • Healthcare Technology and Patient Monitoring
  • Infection Control in Healthcare
  • Neonatal Respiratory Health Research
  • Cystic Fibrosis Research Advances
  • Hormonal Regulation and Hypertension
  • Inflammatory mediators and NSAID effects
  • Food Allergy and Anaphylaxis Research

Tallaght University Hospital
2013-2024

Trinity College Dublin
2024

Bristol-Myers Squibb (United States)
2023

Vhi Healthcare
2017

National Maternity Hospital
2016

Amron (United States)
2004-2008

GlaxoSmithKline (United Kingdom)
2006

Hokkaido University
2005

Johns Hopkins University
2004

Research Triangle Park Foundation
2000

In severe asthma, poor control could reflect issues of medication adherence or inhaler technique, that the condition is refractory. This study aimed to determine if an intervention with (bio)feedback on features use would identify refractory asthma and enhance technique adherence.Patients uncontrolled were subjected a stratified-by-site random block design. The intensive education group received repeated training in use, disease management. same intervention, enhanced by (bio)feedback-guided...

10.1183/13993003.01126-2017 article EN European Respiratory Journal 2018-01-01

Glucocorticosteroids are a very effective treatment for asthma and other chronic inflammatory diseases. However, small proportion of patients is resistant to the therapeutic effects glucocorticoids. Pharmacokinetic ligand binding studies suggest that molecular abnormality in steroid resistance lies distal nuclear translocation. We have previously reported there decreased ability glucocorticoid receptors (GR) bind DNA-binding site peripheral blood mononuclear cells (PBMC) after dexamethasone...

10.1084/jem.182.6.1951 article EN The Journal of Experimental Medicine 1995-12-01

Macrophage migration inhibitory factor (MIF) is an immunologic regulator that expressed in inflammatory and autoimmune disorders. We investigated MIF's role asthma using genetic approaches a mouse model cohort of patients. Mice genetically deficient MIF were primed aerosol-challenged with ovalbumin showed less pulmonary inflammation lower airway hyperresponsiveness than matched, wild-type controls. deficiency also resulted titers specific IgE, IgG(1), IgG(2a), decreased pulmonary, T(H)2...

10.1073/pnas.0507189102 article EN Proceedings of the National Academy of Sciences 2005-09-26

To determine whether electronic monitoring of hand hygiene and voice prompts can improve decrease nosocomial infection rates in a surgical intermediate care unit.Three-phase quasi-experimental design. Phase I was direct observation; phase II computerized for failure to perform on room exit; III only.Nine-room, 14-bed unit university, tertiary-care institution. All patient rooms, utility room, staff lavatory were monitored electronically.All healthcare personnel including physicians, nurses,...

10.1097/01.ccm.0000108866.48795.0f article EN Critical Care Medicine 2004-02-01

BACKGROUND: There are two isoforms of cyclo-oxygenase (COX), namely COX-1 and COX-2. is constitutively expressed in most tissues blood platelets. The metabolites derived from probably involved cellular housekeeping functions. COX-2 only following activation by inflammatory stimuli thought to be inflammation. METHODS: expression isoenzymes has been studied the bronchial mucosa 10 normal 18 asthmatic subjects, 11 whom had aspirin-sensitive asthma (ASA) seven non-aspirin-sensitive (NASA)...

10.1136/thx.52.11.940 article EN Thorax 1997-11-01

Although glucocorticosteroids are a very effective treatment for asthma and other chronic inflammatory diseases, small proportion of patients resistant to their therapeutic effects. The molecular mechanism this steroid resistance is unclear. Steroid cannot be explained by pharmacokinetic mechanisms, defect in the binding steroids glucocorticoid receptors, nor defective nuclear translocation receptor, thereby suggesting that abnormality lies distal translocation. We examined ability...

10.4049/jimmunol.154.7.3500 article EN The Journal of Immunology 1995-04-01

Unstimulated peripheral blood mononuclear cells (PBMCs) from corticosteroid-resistant (CR) but not corticosteroid-sensitive (CS) asthmatics demonstrate increased activating peptide-1 (AP-1)- and decreased glucocorticoid receptor (GR)-DNA binding. We test whether these abnormalities are associated with excessive generation of c-fos, the inducible component AP-1. The c-fos transcription rate, mRNA protein levels, GR-DNA binding were quantitated in PBMCs, T cells, monocytes CS, CR, nonasthmatic...

10.1172/jci2680 article EN Journal of Clinical Investigation 1998-12-15

Accumulating evidence suggests that the cytokine network is central to immunopathology of bronchial asthma and recent findings have suggested naturally occurring antagonists may also be involved. In this study we looked at expression interleukin-1 beta (IL-1beta) its receptor antagonist, IL-1ra, in normal asthmatic wall. Frozen biopsies from 12 18 individuals were double stained with EBM11 (a CD68 macrophage marker) either a rabbit anti-IL-1beta or anti-IL-1ra. Hue-saturation-intensity color...

10.1164/ajrccm.154.4.8887608 article EN American Journal of Respiratory and Critical Care Medicine 1996-10-01

Hemodynamic abnormalities have been implicated in the pathogenesis of increased glomerular permeability to protein diabetic and other glomerulopathies. Vascular factor (VPF) is one most powerful promoters vascular permeability. We studied effect stretch on VPF production by human mesangial cells intracellular signaling pathways involved. The application mechanical (elongation 10%) for 6 h induced a 2.4-fold increase over control mRNA level (P < 0.05). There was corresponding 3-fold 12 0....

10.1073/pnas.94.22.12112 article EN Proceedings of the National Academy of Sciences 1997-10-28

Dual bronchodilation combining a long-acting β2-agonist (LABA) and muscarinic antagonist (LAMA) is the preferred choice of treatment recommended by Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 guidelines management patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). The once-daily (q.d.) fixed-dose combination (FDC) LABA, indacaterol 110 μg LAMA, glycopyrronium 50 (IND/GLY 110/50 q.d.) demonstrated superior improvements in lung function,...

10.1186/s12931-017-0622-x article EN cc-by Respiratory Research 2017-07-18

Corticosteroid-resistant (CR) asthma is not caused by altered bioavailability of the administered drug, ligand-binding characteristics, or nuclear translocation activated human glucocorticoid receptor (hGR) complex. We have tested hypothesis that CR results from a consistent polymorphism in functionally diverse hGR cDNA using sensitive screening technique polymerase chain reaction (PCR) amplification and chemical mutational analysis. Total RNA was extracted peripheral blood monocytes derived...

10.1165/ajrcmb.11.1.8018337 article EN American Journal of Respiratory Cell and Molecular Biology 1994-07-01

10.1016/j.archger.2008.04.007 article EN Archives of Gerontology and Geriatrics 2008-06-04

BACKGROUND: Accumulating evidence suggests that the cytokine network is central to immunopathology of bronchial asthma and existence naturally occurring antagonists has added this complexity. Upregulation both interleukin 1 beta (IL-1 beta) its receptor antagonist, antagonist (IL-1ra), previously been observed on asthmatic epithelium compared with normal airways. METHODS: The effect inhaled beclomethasone dipropionate (BDP) epithelial expression IL-1 IL-1ra was studied. Frozen biopsy...

10.1136/thx.52.5.407 article EN Thorax 1997-05-01

This proof-of-concept study retrospectively assessed the feasibility of applying a hybrid control arm design to completed phase III randomized controlled trial (RCT; CheckMate-057) in advanced non-small cell lung cancer using real-world data (RWD) source. The emulated consists an experimental (patients from RCT cohort) and RWD cohorts). For cohort, this used nationwide electronic health record-derived de-identified database. Three frequentist statistical borrowing methods were evaluated:...

10.1002/cpt.2841 article EN cc-by-nc-nd Clinical Pharmacology & Therapeutics 2023-01-06

&lt;i&gt;Background:&lt;/i&gt; Atopic asthma is an allergic disease typically associated with T&lt;sub&gt;H&lt;/sub&gt;2 cytokines. IL-17A also asthma, through the induction of chemokines. Mucosal CCL28 concentrations correlate cellular recruitment to inflamed airways and support migration IgA&lt;sup&gt;+&lt;/sup&gt; B cells. Here, a link between IL-17A, IgE-secreting cell chemotaxis examined. &lt;i&gt;Methods:&lt;/i&gt; Primary human airway cells epithelial line A549 were used characterize...

10.1159/000322178 article EN International Archives of Allergy and Immunology 2011-01-01
Coming Soon ...